“…Actually, the idiosyncratic properties of DNA and the properties of combinatorial synthesis have excluded many conventional organic reactions that have been widely used in modern synthetic medicinal chemistry from the DEL chemistry toolbox. Fortunately, researchers worldwide have dedicated themselves to developing a set of DNA-compatible chemical reactions, for instance, diazo-transfer, diarylether synthesis, amide formation, hydrogenation, cross-coupling reaction, − ring-closing metathesis, C–H activation and functionalization, − photopromoted reaction, sulfur-fluoride exchange (SuFEx) click chemistry, bioinspired click selenylation, , cycloaddition reaction, and the on-DNA synthesis of privileged heterocycles such as isocoumarin, azoles, benzimidazole, pyrazoline, pyrrole, and others. ,− Even so, continuously expanding the toolbox of DNA-compatible chemical reactions that can fulfill the stringent criteria of high fidelity, good conversions, chemoselectivity, predictability, and broad substrate scope is still the pillar to promote the future development of DEL technology.…”